NCI director says institute is ‘stable’ after turbulent year
During a session at AACR 2026, NCI Director Anthony Letai, MD, PhD, said that despite a turbulent past year, the institute is stable
During a session at AACR 2026, NCI Director Anthony Letai, MD, PhD, said that despite a turbulent past year, the institute is stable
We would like to inform you of an important update regarding the 4th SOHO-Israel Meeting & 10th International Davidoff Conference. In light of
At the AACR-Oncology Partnering event, Richard Pazdur, former FDA-OCE director discusses FDA morale, politics and AI shift.
Human intelligence will be more important than ever as artificial intelligence continues to proliferate throughout clinical care, according Yu Shyr, PhD, FAACR, chair
The US Food and Drug Administration (FDA) has granted Fast Track Designation to OPN-6602, an oral small-molecule EP300/CBP inhibitor, for patients with relapsed
The award recognizes an individual's achievements and contributions in any aspect of blood cancer research.
SOHO will hold an exclusive session titled, “Practical Strategies for Optimizing Outcomes in MDS and AML,” starting at 3 pm on Tuesday, September
The researchers added that early indications from their translational substudies suggest that PET radiomics and immune gene analyses provide promise as biomarkers for
Don’t miss the SOHO 2026 poster walks taking place from Wednesday to Friday during the SOHO 2026 Annual Meeting. More information at soho.click/2026.
When multiple myeloma and chronic lymphocytic leukemia appear in the same patient, they do not derive from the same B-cell but rather develop